2023-03-27
Festival of Biologics USA旨在为生物医药发现、开发、制造、定价和市场准入等提供一个专业交流与合作的平台，与会者在此分享研究成果。大湾生物CEO陈亮博士分享了智能化定点整合技术商业化平台AlfaCell®在DNA到RCB构建，细胞株授权许可以及定点整合细胞株联合开发等方面的技术服务优势，并与多个制药和生物技术企业、投资机构等建立了新的合作机会。
Platform Case | AI Tackles Challenging GPCR Drug Target in 8 Months! AlfaBodY Platform of Great Bay Bio Generates Long-Acting Non-Rebound Weight-Loss Antibody; Research Findings Published
2026-07-17
Technology Platform | AlfaBodY Intelligent Molecular Design Platform Powers New Drug R&D: Deliver PCC+ in 8 Months and Conquer Hard-to-Drug Targets
2026-06-25
Tech Platform | AlfaDAX Platform Iteratively Optimizes Nanobodies, Delivering a 10-Fold Affinity Improvement in 1.5 Months
2026-06-10
